Trial seeking kids allergic to egg to test pioneering allergy treatment
12 June 2020 A trial led by the Murdoch Children’s Research Institute (MCRI) is recruiting 80 children and adolescents allergic to egg to test a pioneering new approach to food allergies. MCRI Professor Mimi Tang is developing a probiotic and peanut immunotherapy…
CSL to Acquire Biotech Company Vitaeris
9 June 2020 CSL Limited announced that it has agreed to exercise its right to acquire Vitaeris Inc., a clinical-stage biotechnology company focused on the phase III development of a treatment for rejection in solid organ kidney transplant…
AdAlta Receives Approval to Commence Phase 1 Clinical Trial of AD-214
10 June 2020 Highlights Human Research Ethics Committee approves Phase I human clinical trial of AD-214 No further regulatory review required First healthy volunteer subject expected to receive AD-214 in late July Top-line safety results from healthy volunteer…
NASA’s JPL selects Planet Innovation to manufacture ventilator in Australia
9 June 2020 NASA’s Jet Propulsion Laboratory has selected Planet Innovation as the only Australian manufacturer of a new ventilator tailored for COVID-19 patients. PI is among 13 international companies and eight U.S. manufacturers selected from more than…
The University of Queensland, CEPI and CSL partner to advance development and manufacture of COVID-19 vaccine candidate
5 June 2020 • CSL appointed Trusted Manufacturer for University of Queensland’s “molecular clamp” enabled COVID-19 vaccine candidate • CEPI and CSL will share costs associated with the clinical development and manufacture of the vaccine candidate • A…
Monash University and oNKo-innate Announce Research Partnership
4 June 2020 An innovative research partnership has been established between Monash University and new Melbourne-based start up, oNKo-innate Pty Ltd. The unique partnership sees oNKo-innate, co-founded by Professor Nicholas Huntington and Dr Jai Rautela, being based at the Monash Biomedicine Discovery…
Muscle tech: Sleep apnea therapeutic showcased at global biotech event
4 June 2020 A world-first therapeutic for treating sleep apnea and a range of other weak muscle conditions will be unveiled this month at global biotech innovation event, BIO Digital. Developed by RMIT in collaboration with Snoretox Pty…
World First In 3D Printing Gives A Personal Touch To Keep The Blood Flowing
4 June 2020 Researchers from CSIRO, Australia’s national science agency, have made it possible to 3D print tailor-made stents, a critical biomedical device used to treat narrow or blocked arteries. The breakthrough, made in partnership with Wollongong-based Medical…
Australian Government invests in new medicines for COVID-19
2 June 2020 The Australian Government will invest $3M in Walter and Eliza Hall Institute research programs that are developing new classes of medicines for COVID-19. The funding from the Medical Research Future Fund (MRFF) will support…
Dimerix Drug in WHO COVID-19 Trial
4 June 2020 Global platform trial taps Australian drug for major global COVID-19 treatment study As the world mobilises to bring to bear the full scientific resources it can to fight the COVID-19 pandemic, an Australian biotech…
AbbVie and Jacobio Announce Strategic Collaboration to Advance SHP2 Inhibitors
1 June 2020 AbbVie, a research-based global biopharmaceutical company, and Jacobio Pharmaceuticals, a clinical-stage pharmaceutical company, today announced a global, strategic collaboration to develop and commercialize SHP2 inhibitors, which target a key node in cancer and immune cells. SHP2 is…
Certara Broadens and Increases Regulatory Strength with Two Executive Hires
21 May 2020 Certara®, the global leader in model-informed drug development and regulatory science announced the appointments of Terrance (Terry) Ocheltree, Ph.D., R.Ph. as vice president of regulatory strategy and chemistry, manufacturing and controls (CMC) and Lynne Georgopoulos,…
